Surveillance Strategies after Curative Treatment of Colorectal Cancer
- 3 June 2004
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 350 (23) , 2375-2382
- https://doi.org/10.1056/nejmcp010529
Abstract
A 63-year-old man underwent complete resection of a T3N0M0, stage II adenocarcinoma of the ascending colon. No adjuvant therapy is planned. There is no family history of colorectal cancer. How should he be followed?Keywords
This publication has 44 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Colorectal cancer follow-up: a reassessment of empirical evidence on effectivenessEuropean Journal of Surgical Oncology, 2000
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999
- Defining optimal treatment for stage II colon cancer: Does decision analysis help?Gastroenterology, 1999
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Role of follow-up in management of local recurrences of colorectal cancerDiseases of the Colon & Rectum, 1998
- The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancerDiseases of the Colon & Rectum, 1994
- Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous PolypsNew England Journal of Medicine, 1993